iTBS

Testing a New Way to Precisely Target and Predict the Impact of TMS Brain Stimulation for Depression
As non-invasive brain stimulation—variations of TMS (transcranial magnetic stimulation)—continues to evolve and is administered to a growing number of patients with depression (and other illnesses,… Read More
Two Forms of Non-Invasive Brain Stimulation Helped Older Adults with Treatment-Resistant Depression
Depression that doesn’t respond to conventional treatments is a serious problem for all who are affected, and poses unique risks for those over 60.  Late-life depression is often complicated by the… Read More
Adding an Antibiotic Improved Brain Stimulation Results in Depression
The two prevalent forms of non-invasive brain stimulation treatment for major depressive disorder have a well-documented ability to help patients, including some who have not been helped by popular… Read More
FDA Clears SAINT Rapid-Acting Brain Stimulation Approach for Those Suffering From Resistant Major Depression
On September 6, 2022, the U.S. Food and Drug Administration cleared the way for marketing of a rapid-acting brain-stimulation approach for major depressive disorder pioneered by Nolan Williams, M.D… Read More
In Major Depression, Accelerated rTMS Brain Stimulation Shows Promise
Researchers have obtained encouraging results in an early test of an accelerated form of non-invasive brain stimulation to treat major depressive disorder. Read More